Delivery Order SPE2DB22D1017-SPE2DB25FE7VV
Award Date
10/24/24
Potential Completion Date
10/25/24
Potential Value
$7.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,342.10 contract is a Firm Fixed Price Delivery Order for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 21, 2024. This award is associated with AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $24,177.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 21, 2024 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The $6,128.85 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $17,458.37, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 5, 2024, and is a firm fixed-price contract. The award was not subject to any set-aside requirements, indicating open...
This federal contract award, valued at $10,487.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order for the supply of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,022.67 firm fixed-price delivery order is for the provision of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of January 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ELIQUIS 5 MG TABLET 60S. The $34,745.56 firm fixed-price delivery order contract has a completion date of May 28, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award, valued at $1,084.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of March 13, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,656.78, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is structured as a Firm Fixed Price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,517.32 firm fixed price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...